Treatment with interleukin-11 affects plasma leptin levels in inflamed and non-inflamed rabbits

Regulatory Peptides

Volumn 122, Issue 3, 2004, Pages 149-156

  Depoortere, Inge ^a   Thijs, Theo ^a   Keith Jr , James ^b   Peeters, Theo L ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b PFIZER INC   (United States)

Author keywords

Colitis; Cytokines; Leptin; Motilin

Indexed keywords

INTERLEUKIN 11; LEPTIN; MESSENGER RNA; MOTILIN; PEPTIDE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; COLITIS; CONTROLLED STUDY; DOSE RESPONSE; FEEDBACK SYSTEM; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; WASTING SYNDROME; WEIGHT REDUCTION;

ANIMALS; CELL LINE; COLITIS; GENE EXPRESSION REGULATION; INFLAMMATION; INTERLEUKIN-11; LEPTIN; MOTILIN; RABBITS; RNA, MESSENGER; WEIGHT LOSS;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 5644286495     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2004.06.006     Document Type: Article

References (36)

1. Tepler I., Elias L., Smith J.W. Jr., Hussein M., Rosen G., Chang A.Y., et al. A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy. Blood. 87:1996;3607-3614
2. Du X.X., Williams D.A. Interleukin-11: a multifunctional growth factor derived from the hematopoietic microenvironment. Blood. 83:1994;2023-2030
3. Du X., Williams D.A. Interleukin-11: review of molecular, cell biology, and clinical use. Blood. 89:1997;3897-3908
4. Sands B.E., Bank S., Sninsky C.A., Robinson M., Katz S., Singleton J.W., et al. Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease. Gastroenterology. 117:1999;58-64
5. Sands B.E., Winston B.D., Salzberg B., Safdi M., Barish C., Wruble L., et al. Randomized, controlled trial of recombinant human interleukin-11 in patients with active Crohn's disease. Aliment. Pharmacol. Ther. 16:2002;399-406
6. Snape W.J. Jr., Williams R., Hyman P.E. Defect in colonic smooth muscle contraction in patients with ulcerative colitis. Am. J. Physiol. 261:1991;G987-G991
7. Vermillion D.L., Huizinga J.D., Riddell R.H., Collins S.M. Altered small intestinal smooth muscle function in Crohn's disease. Gastroenterology. 104:1993;1692-1699
8. Depoortere I., Van Assche G., Thijs T., Geboes K., Peeters T.L. Differential changes in ACh-, motilin-, substance P-, and K(+)-induced contractility in rabbit colitis. Am. J. Physiol. 277:1999;G61-G68
9. Martinolle J.P., Garcia-Villar R., Fioramonti J., Bueno L. Altered contractility of circular and longitudinal muscle in TNBS-inflamed guinea pig ileum. Am. J. Physiol. 272:1997;G1258-G1267
10. Depoortere I., Thijs T., Van Assche G., Keith J.C. Jr., Peeters T.L. Dose-dependent effects of recombinant human interleukin-11 on contractile properties in rabbit 2,4,6-trinitrobenzene sulfonic acid colitis. J. Pharmacol. Exp. Ther. 294:2000;983-990
11. Greenwood-Van Meerveld B., Venkova K., Keith J.C. Jr. Recombinant human interleukin-11 restores smooth muscle function in the jejunum and colon of human leukocyte antigen-B27 rats with intestinal inflammation. J. Pharmacol. Exp. Ther. 299:2001;58-66
12. Depoortere I., Thijs T., Thielemans L., Keith J.C., Van Assche G., Peeters T.L. Effect of recombinant human interleukin-11 on motilin and substance P release in normal and inflamed rabbits. Regul. Pept. 97:2001;111-119
13. Asakawa A., Inui A., Momose K., Ueno N., Fujino M.A., Kasuga M. Motilin increases food intake in mice. Peptides. 19:1998;987-990
14. Rosenfeld D.J., Garthwaite T.L. Central administration of motilin stimulates feeding in rats. Physiol. Behav. 39:1987;753-756
15. Garthwaite T.L. Peripheral motilin administration stimulates feeding in fasted rats. Peptides. 6:1985;41-44
16. Tracey K.J., Wei H., Manogue K.R., Fong Y., Hesse D.G., Nguyen H.T., et al. Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J. Exp. Med. 167:1988;1211-1227
17. Bendtzen K. Interleukin 1, interleukin 6 and tumor necrosis factor in infection, inflammation and immunity. Immunol. Lett. 19:1988;183-191
18. Black K., Garrett I.R., Mundy G.R. Chinese hamster ovarian cells transfected with the murine interleukin-6 gene cause hypercalcemia as well as cachexia, leukocytosis and thrombocytosis in tumor-bearing nude mice. Endocrinology. 128:1991;2657-2659
19. McHugh K.J., Collins S.M., Weingarten H.P. Central interleukin-1 receptors contribute to suppression of feeding after acute colitis in the rat. Am. J. Physiol. 266:1994;R1659-R1663
20. Siegmund B., Lehr H.A., Fantuzzi G. Leptin: a pivotal mediator of intestinal inflammation in mice. Gastroenterology. 122:2002;2011-2025
21. Grunfeld C., Zhao C., Fuller J., Pollack A., Moser A., Friedman J., et al. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J. Clin. Invest. 97:1996;2152-2157
22. Sarraf P., Frederich R.C., Turner E.M., Ma G., Jaskowiak N.T., Rivet D.J. III, et al. Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J. Exp. Med. 185:1997;171-175
23. Janik J.E., Curti B.D., Considine R.V., Rager H.C., Powers G.C., Alvord W.G., et al. Interleukin 1 alpha increases serum leptin concentrations in humans. J. Clin. Endocrinol. Metab. 82:1997;3084-3086
24. Zumbach M.S., Boehme M.W., Wahl P., Stremmel W., Ziegler R., Nawroth P.P. Tumor necrosis factor increases serum leptin levels in humans. J. Clin. Endocrinol. Metab. 82:1997;4080-4082
25. Barbier M., Cherbut C., Aube A.C., Blottiere H.M., Galmiche J.P. Elevated plasma leptin concentrations in early stages of experimental intestinal inflammation in rats. Gut. 43:1998;783-790
26. Ballinger A., Kelly P., Hallyburton E., Besser R., Farthing M. Plasma leptin in chronic inflammatory bowel disease and HIV: implications for the pathogenesis of anorexia and weight loss. Clin. Sci. (Lond.). 94:1998;479-483
27. Hoppin A.G., Kaplan L.M., Zurakowski D., Leichtner A.M., Bousvaros A. Serum leptin in children and young adults with inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 26:1998;500-505
28. Otterness I.G., Seymour P.A., Golden H.W., Reynolds J.A., Daumy G.O. The effects of continuous administration of murine interleukin-1 alpha in the rat. Physiol. Behav. 43:1988;797-804
29. Rachmilewitz D., Simon P.L., Schwartz L.W., Griswold D.E., Fondacaro J.D., Wasserman M.A. Inflammatory mediators of experimental colitis in rats. Gastroenterology. 97:1989;326-337
30. McHugh K.J., Weingarten H.P., Keenan C., Wallace J.L., Collins S.M. On the suppression of food intake in experimental models of colitis in the rat. Am. J. Physiol. 264:1993;R871-R876
31. Ballinger A., El-Haj T., Perrett D., Turvill J., Obeid O., Dryden S., et al. The role of medial hypothalamic serotonin in the suppression of feeding in a rat model of colitis. Gastroenterology. 118:2000;544-553
32. Nonogaki K., Strack A.M., Dallman M.F., Tecott L.H. Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene. Nat. Med. 4:1998;1152-1156
33. Flier J.S., Maratos-Flier E. Obesity and the hypothalamus: novel peptides for new pathways. Cell. 92:1998;437-440
34. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 402:1999;656-660
35. Dahmen H., Horsten U., Kuster A., Jacques Y., Minvielle S., Kerr I.M., et al. Activation of the signal transducer gp130 by interleukin-11 and interleukin-6 is mediated by similar molecular interactions. Biochem. J. 331:1998;695-702
36. Quandt K., Frech K., Karas H., Wingender E., Werner T. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23:1995;4878-4884